A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.
Startup Gameto has developed a technique for maturing eggs outside the body that’s showing promise at helping patients get pregnant with fewer hormone treatments.
In an advance for treating male infertility, researchers transplanted a patient with his own sperm-forming stem cells that were collected from testicular tissue when he was a child.
The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical disabilities to have more natural interactions with the world around them.
Measles is known for its characteristic rash, but it can have serious respiratory and neurologic complications.
The brain implant company cofounded by Elon Musk is moving to trademark several product names, including Telepathy and Telekinesis.
With egg prices soaring, the US is considering vaccinating laying chickens, which have been hit particularly hard by the avian influenza outbreak.
Biohacker Josie Zyner’s new company, Los Angeles Project, is creating a new generation of gene-edited pets.
Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are capable of decoding what they smell.
Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as desire itself.